BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 8778233)

  • 1. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro.
    Sawangjaroen K; Sernia C; Curlewis JD
    J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro.
    Sawangjaroen K; Anderson ST; Curlewis JD
    J Neuroendocrinol; 1997 Apr; 9(4):279-86. PubMed ID: 9147291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
    Suzuki A; Kotoyori J; Oiso Y; Kozawa O
    Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells.
    Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK
    J Endocrinol; 1996 May; 149(2):287-95. PubMed ID: 8708540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro.
    Heindel JJ; Sneeden J; Powell CJ; Davis B; Culler MD
    Biol Reprod; 1996 Mar; 54(3):523-30. PubMed ID: 8835372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K; Connell TD; Higgins D
    J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence.
    Schomerus C; Maronde E; Laedtke E; Korf HW
    Cell Tissue Res; 1996 Dec; 286(3):305-13. PubMed ID: 8929333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide- and VIP-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists.
    Samuelsson-Almén M; Nilsson SF
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):389-400. PubMed ID: 10530700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pituitary adenylate cyclase activating polypeptide on vasopressin-induced proliferation of aortic smooth muscle cells: comparison with vasoactive intestinal polypeptide.
    Oiso Y; Kotoyori J; Murase T; Ito Y; Kozawa O
    Biochem Cell Biol; 1993; 71(3-4):156-61. PubMed ID: 7691092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta.
    Hezareh M; Schlegel W; Rawlings SR
    J Neuroendocrinol; 1996 May; 8(5):367-74. PubMed ID: 8736436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity.
    Foda HD; Sharaf HH; Absood A; Said SI
    Peptides; 1995; 16(6):1057-61. PubMed ID: 8532588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide stimulates secretion in T84 cells.
    Nguyen TD; Heintz GG; Cohn JA
    Gastroenterology; 1992 Aug; 103(2):539-44. PubMed ID: 1321772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.